Bay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials Post author:Sam Post published:February 7, 2018 Post category:BioPharma Rani said the latest funding round brings its coffers a total of $142M. Source: BioSpace You Might Also Like Commonwealth Diagnostics Announces U.S. Launch And New Global Developments August 30, 2017 <b>Mapi Research Trust</b> Appointed As Exclusive Distributor And Mapi Language Services As Exclusive Translator Of The "Disease Activity Score (DAS-28)" July 6, 2017 ProQR Therapeutics Spins Out CNS-Focused Biotech, September 11, 2017
<b>Mapi Research Trust</b> Appointed As Exclusive Distributor And Mapi Language Services As Exclusive Translator Of The "Disease Activity Score (DAS-28)" July 6, 2017
